 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Pharmacokinetic data | |
| Eliminationhalf-life | 2.5 hr[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| IUPHAR/BPS | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.022.289 |
| Chemical and physical data | |
| Formula | C13H9F3N2O2 |
| Molar mass | 282.222 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 204 °C (399 °F) |
| |
| |
 N Y (what is this?) (verify) | |
Niflumic acid is a drug used for joint and muscular pain. It is categorized as an inhibitor ofcyclooxygenase-2. In experimental biology, it has been employed to inhibitchloride channels.[2] It has also been reported to act on GABA-A[3] andNMDA channels[4] and to block T-type calcium channels.[5]
| pyrazolones / pyrazolidines | |
|---|---|
| salicylates | |
| acetic acid derivatives and related substances | |
| oxicams | |
| propionic acid derivatives (profens) |
|
| n-arylanthranilic acids (fenamates) | |
| COX-2 inhibitors (coxibs) | |
| other | |
| NSAID combinations | |
Key:underline indicates initially developed first-in-class compound of specific group;#WHO-Essential Medicines;†withdrawn drugs;‡veterinary use. | |
 | Thisdrug article relating to themusculoskeletal system is astub. You can help Wikipedia byexpanding it. |
